Compare Align Technology, Inc. (ALGN) vs Royal Bank of Canada (RY) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Align Technology, Inc. vs Royal Bank of Canada — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while Royal Bank of Canada trades at $208.97 (market cap $292.49B). The key difference: Royal Bank of Canada is far larger — about 22.7× Align Technology, Inc.'s market cap, and Royal Bank of Canada pays a 2.42% dividend while Align Technology, Inc. pays none. Which is the better fit depends on your goals.
| ALGN | RY | |
|---|---|---|
Market Cap | $12.86B | $292.49B |
Sector | Health | Financials |
52-Week High | $207.19 | $211.09 |
52-Week Low | $124.88 | $128.46 |
Enterprise Value | $11.92B | — |
Dividend Yield | — | 2.42% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
Royal Bank of Canada (RY) trades at $211.09, up 1.21% today, with a bullish technical signal and strong fundamental performance. Recent quarterly earnings consistently beat estimates, with Q1 2026 EPS of $2.84 exceeding the $2.81 forecast. Revenue grew to $66.53B in 2025, and net income margin improved to 31.85%. The company maintains a solid dividend, recently increasing it to $1.76 per share, and announced a share repurchase program.
RY's outlook is positive, supported by earnings momentum and shareholder returns, but faces risks from economic softness and high valuation multiples. Analyst sentiment is mixed, with a majority hold rating, reflecting caution amid rich valuations. The stock's current price near resistance at $211 suggests potential for consolidation before further gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About Royal Bank of Canada
Royal Bank of Canada is one of the two largest banks in Canada. It is a diversified financial services company, offering personal and commercial banking, wealth-management services, insurance, corporate banking, and capital markets services. The bank is concentrated in Canada, with additional operations in the U.S. and other countries.
Read more on RY →
